PRF1 and ovarian carcinoma: In addition, as seen in ovarian cancer, there was also a clear link between the expression of IFNG, CXCL13, CD30, and PRF1 and presence of immune cells within the tumor, including B cells, CD8+ T cells, CD4+ T cells, dendritic cells, and neutrophils.